GMO co-founder Jeremy Grantham warns of risks in SpaceX's record IPO
Solo los hechos

GMO co-founder Jeremy Grantham warns of risks in SpaceX's record IPO

Resumen

Jeremy Grantham, co-founder of GMO, called SpaceX's $75 billion Nasdaq-100 debut the most extreme IPO ever and cautioned investors about its valuation and long-term outlook.

SpaceX entered the Nasdaq-100 index after its initial public offering raised $75 billion, the largest IPO on record. The company’s shares opened at $150, above the $135 listing price, and were trading near $149 on Wednesday, down about 7 % for the month.

GMO co-founder Jeremy Grantham, known for his bearish market outlook, expressed strong skepticism on Morningstar’s "The Long View" podcast. He said, "Everyone’s lining up to tell you to buy the craziest IPO in the history of man," and warned that future investors may look back and question the valuation. Grantham added that the inclusion of SpaceX in the Nasdaq-100 will force many index funds to purchase the stock, creating demand that could push the price higher, but he questioned the sustainability of such growth.

Analysts at Goldman Sachs, JPMorgan and Morgan Stanley have set price targets between $205 and $300 per share, indicating a bullish view of the company’s prospects. SpaceX, founded in 2002, is the world’s largest commercial launch provider and a key contractor for NASA and U.S. government missions, noted for its reusable rocket technology that has lowered launch costs.

The IPO also increased Elon Musk’s personal wealth toward the $1 trillion mark, making him the richest individual globally.

Sigue leyendo, gratis

Crea una cuenta gratis para seguir las noticias. No se requiere tarjeta.